In this article, we explore the experiences of sickle cell patients in emergency care and the ways they can advocate for themselves ...

As one of the world’s foremost medical universities, KI accounts for the single largest share of all academic medical research conducted in Sweden. KI also offers the country’s broadest range of ...

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new ...

Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company with a market capitalization of $156.6 million, is at a pivotal juncture in its development of programmed cellular ...

Objectives Patients with SLE take multiple medications. Within a large prospective longitudinal SLE cohort, we characterised ...

Systemic lupus erythematosus, more commonly known as lupus, has a variety of symptoms and room for improvement when it comes ...

Genetically predicted rheumatoid arthritis (RA) is causally associated with prostate cancer (PCa), according to a study ...

Objective Metabolic reprogramming plays a critical role in modulating the innate and adaptive immune response, but its role ...

We detected ANA in 5/9 of the SLE patients and none of the 7 HD sera. The same subjects with positive ANA in the serum, also had positive ANA in the BM supernatant as shown in Figures 9B, C. Of note, ...

Lin et al. reviewed the issue of SLE disease activity assessment both in clinical practice and research. It was initially acknowledged that activity indices are important for routine treat -to -target ...

However, these "skinny" plans are not comprehensive enough to be considered major medical coverage. Also note that while Medicare Part A is considered minimum essential coverage, Medicare Part B on ...